Non-genomic effects of nuclear receptors: insights from the anucleate platelet
Open accessThe DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index.
Abstract
Nuclear receptors (NRs) have the ability to elicit two different kinds of responses, genomic and non-genomic. Although genomic responses control gene expression by influencing the rate of transcription, non-genomic effects occur rapidly and independently of transcriptional regulation. Due to their anucleate nature and mechanistically well-characterized and rapid responses, platelets provide a model system for the study of any non-genomic effects of the NRs. Several NRs have been found to be present in human platelets, and multiple NR agonists have been shown to elicit anti-platelet effects by a variety of mechanisms. The non-genomic functions of NRs vary, including the regulation of kinase and phosphatase activity, ion channel function, intracellular calcium levels, and production of second messengers. Recently, the characterization of mechanisms and identification of novel binding partners of NRs have further strengthened the prospects of developing their ligands into potential therapeutics that offer cardio-protective properties in addition to their other defined genomic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lastly, NRs may also harbor non-genomic functions right after biosynthesis, which however are still yet not fully elucidated.[44]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management
Beckman, J. A., Creager, M. A., & Libby, P. (2002) · JAMA · doi:10.1001/jama.287.19.2570 · Cited by 2,724
PPARγ signaling and metabolism: the good, the bad and the future
Ahmadian, M., Suh, J. M., Hah, N., Liddle, C., Atkins, A. R., Downes, M., & Evans, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3159 · Cited by 2,016
Roles of PPARs in health and disease
Kersten, S., Desvergne, B., & Wahli, W. (2000) · Nature · doi:10.1038/35013000 · Cited by 1,956
Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators
McKenna, N. J., & O'Malley, B. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00641-4 · Cited by 1,463 · cited 1×
“The formation of different multi-protein signalling complexes with different localization and distribution patterns across different cell types could offer a high degree of cell and tissue selective action for the NRs but as of yet these are poorly defined.(10,11)”
Nuclear Receptors, RXR, and the Big Bang
Evans, R. M., & Mangelsdorf, D. J. (2014) · Cell · doi:10.1016/j.cell.2014.03.012 · Cited by 1,200
Tanaka, M., Yamamoto, Y., Misawa, E., Nabeshima, K., Saito, M., Yamauchi, K., Abe, F., & Furukawa, F. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000454718 · Cited by 1,092
Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production
Boilard, E., Nigrovic, P. A., Larabee, K., Watts, G. F. M., Coblyn, J. S., Weinblatt, M. E., Massarotti, E. M., Remold-O’Donnell, E., Farndale, R. W., Ware, J., et al. (2010) · Science · doi:10.1126/science.1181928 · Cited by 1,085
Chinetti, G., Fruchart, J.-C., & Staels, B. (2000) · Inflammation Research · doi:10.1007/s000110050622 · Cited by 954
Glucocorticoid receptor signaling in health and disease
Kadmiel, M., & Cidlowski, J. A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.07.003 · Cited by 849
Research works printed but not linked: 1
- Unsworth, 2017, PPARgamma agonists negatively regulate alphaIIbbeta3 integrin outside-in signalling and platelet function through upregulation of protein kinase A activity, J Thromb Haemost, 15, 356, 10.1111/jth.13578 · DOI
Cited by
A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes
Flora, G. D., & Nayak, M. K. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190925163827 · Cited by 476
Self-citation25-Hydroxycholesterol as a Signaling Molecule of the Nervous System
Odnoshivkina, Y. G., Kuznetsova, E. A., & Petrov, A. M. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922060049 · Cited by 296
“25-HC is a strong natural activator of LXRs [3] present in the plasma membranes (lipid rafts) of some cells [82, 83].”
BackgroundInnate immune receptors in platelets and platelet-leukocyte interactions
Dib, P. R. B., Quirino-Teixeira, A. C., Merij, L. B., Pinheiro, M. B. M., Rozini, S. V., Andrade, F. B., & Hottz, E. D. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mr0620-701r · Cited by 166
Platelets and diseases: signal transduction and advances in targeted therapy
Tian, Y., Yao, Z., Pang, Y., Zheng, Z., Ma, Y., Zhang, C., & Gao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02198-8 · Cited by 143
“497 Because platelets lack cell nuclei, several NRs present in human platelets can trigger non-genomic effects by physically interacting with cofactors and binding partners.”
Mapping the Azolog Space Enables the Optical Control of New Biological Targets
Morstein, J., Awale, M., Reymond, J., & Trauner, D. H. (2019) · ACS Central Science · doi:10.1021/acscentsci.8b00881 · Cited by 103
Metadata
- Authors
- Unsworth, A. J., Flora, G. D., & Gibbins, J. M.
- Affiliations
- School of Biological Sciences, Institute of Cardiovascular and Metabolic Research, Harborne Building, Whiteknights, Reading RG6 6AS, Berkshire, UK
- Corresponding author
- Gibbins, Jonathan M
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-02-14
- Volume
- 114
- Issue
- 5
- Pages
- 645-655
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- PMC
- PMC5915957
- OpenAlex
- W2786404210
- Cited by
- 54
- References
- 108
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 3 · 2023: 10 · 2022: 5 · 2021: 6 · 2020: 5 · 2019: 7 · 2018: 3
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cardiovascular Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CentAUR (University of Reading) (acceptedVersion)
- e-space (Manchester Metropolitan University) (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- British Heart Foundation (RG/15/2/31224)
- Felix Scholarship
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- nuclear receptors, non-genomic signaling, platelets, anucleate cells, antiplatelet activity, ion channel function, intracellular calcium, second messengers
- MeSH terms
- Animals, Blood Platelets, Fibrinolytic Agents, Humans, Ligands, Platelet Aggregation Inhibitors, Protein Binding, Thrombosis, Signal Transduction, Receptors, Cytoplasmic and Nuclear
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non-genomic effects of nuclear receptors: insights from the anucleate platelet. https://app.cochat.ai/papers/10.1093/cvr/cvy044
- The paper
- Unsworth, A. J., Flora, G. D., & Gibbins, J. M. (2018). Non-genomic effects of nuclear receptors: insights from the anucleate platelet. Cardiovascular Research. https://doi.org/10.1093/cvr/cvy044
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.